Next Article in Journal
A Novel CDK4/6 and PARP Dual Inhibitor ZC-22 Effectively Suppresses Tumor Growth and Improves the Response to Cisplatin Treatment in Breast and Ovarian Cancer
Next Article in Special Issue
Small-Molecule RAS Inhibitors as Anticancer Agents: Discovery, Development, and Mechanistic Studies
Previous Article in Journal
Natural and Synthetic Compounds for Management, Prevention and Treatment of Obesity
Previous Article in Special Issue
Monitoring TRPC7 Conformational Changes by BRET Following GPCR Activation
 
 
Review

Article Versions Notes

Int. J. Mol. Sci. 2022, 23(5), 2891; https://doi.org/10.3390/ijms23052891
Action Date Notes Link
article xml file uploaded 7 March 2022 12:02 CET Original file -
article xml uploaded. 7 March 2022 12:02 CET Update https://www.mdpi.com/1422-0067/23/5/2891/xml
article pdf uploaded. 7 March 2022 12:02 CET Version of Record https://www.mdpi.com/1422-0067/23/5/2891/pdf
article html file updated 7 March 2022 12:03 CET Original file -
article html file updated 1 August 2022 04:27 CEST Update https://www.mdpi.com/1422-0067/23/5/2891/html
Back to TopTop